Beta-blockers in Hypertensive Left Ventricular Hypertrophy and Atrial Fibrillation Prevention

CONCLUSION: BBs are recommended (as a class) for AF prevention in several contemporary guidelines for HTN. LVH regression in HTN - used as a single criterion for the choice of antihypertensive medication - does not capture this protective effect. Consequently, it is worth studying how meaningful this antiarrhythmic action (to prevent AF) of BBs is in patients with HTN LVH in addition to a RAAS blocker.PMID:38031765 | DOI:10.2174/0115701611264647231110101700

Source: Current Vascular Pharmacology - November 30, 2023 Category: Drugs & Pharmacology Authors: Goran Koracevic Sladjana Micic Milovan Stojanovic Marija Zdravkovic Dragan Simic Tomislav Kostic Vesna Atanaskovic Ruzica Tomasevic Jankovic Source Type: research